Kewaunee Scientific

KEQU · NASDAQ

$32.92+$0.82 (+2.55%)TodayMarket closed ·
No price history for this range.

Key indicators

KEQU profitability and balance sheet ratios

EPS $0.584 in Q1 FY27, down 44.1% on a year earlier.

EPS by quarter
PeriodEPS
Q2 FY25$1.01
Q3 FY25$0.4521
Q4 FY25$1.63
Q1 FY26$1.04
Q2 FY26$0.8177
Q3 FY26$0.232
Q4 FY26$1.13
Q1 FY27$0.584

Where the money went

Q1 FY27, from revenue to net income

Kewaunee Scientific brought in $66.3M of revenue in Q1 FY27, −6.7% on a year earlier. 3¢ of every dollar became profit.

Revenue
$66.3M
Costs, expenses and taxes
$64.6M
Net income
$1.7M
Net margin
2.6%

Income statement

Revenue and profit by reporting period

Revenue
Net income
KEQU income statement, quarterly
Line itemQ3 FY26Q4 FY26Q1 FY27
Revenue$69.4M$71.4M$66.3M
Gross profit$18.5M$21.2M$19.6M
Operating income$2.6M$5.2M$3.2M
Net income$0.7M$3.4M$1.7M
Diluted EPS$0.23$1.13$0.58

Balance sheet

What the company owns and owes at period end

Total assets
Total liabilities
KEQU balance sheet, quarterly
Line itemJan 2026Apr 2026Jul 2026
Total assets$176.0M$178.3M$175.8M
Total liabilities$105.3M$103.6M$100.8M
Shareholder equity$70.7M$74.7M$75.0M
Cash and short-term investments$8.2M$10.0M$8.2M
Total debt$49.7M$46.8M$45.9M

Cash flow

Cash in and out from operations, investing and financing

Operating
Investing
Financing
KEQU cash flow, quarterly
Line itemQ3 FY26Q4 FY26Q1 FY27
Operating cash flow$11.6M$5.5M$2.0M
Investing cash flow−$0.7M−$0.9M−$0.8M
Financing cash flow−$14.1M−$3.0M−$2.5M
Capital expenditure−$0.7M−$0.9M−$0.8M
Free cash flow$11.0M$4.5M$1.2M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.